Book Navigation

We are sorry, but signing in with LinkedIn is not possible at this time.


Scientific Committee 2012

Chair of the Scientific Committee

Ina Kopp.jpgIna Kopp (Germany)

Ina Kopp is extraordinary Professor and Director of the German Association of the Scientific Medical Societies´ Institute of Medical Knowledge-Management (AWMF-IMWi) at Philipps-University, Marburg. AWMF-IMWi is the Clearinghouse of Clinical Practice Guidelines developed by the 156 specialty societies organised under the umbrella of AWMF. Dr Kopp serves as coordinator and consultant for CPG development and oversees the internet distribution of CPGs, related information and tools for guideline developers via the AWMF-website. She is vice chair of AWMF´s Standing Commission for Clinical Practice Guidelines and represents AWMF in the National Programme for Disease Management Guidelines and in the Programme for Guidelines in Oncology in Germany. She is involved in several quality initiatives on the national level such as the National Project for Cross-Sectoral Quality in Health Care and the National Cancer Plan of the Federal Ministry of Health. She trained in general surgery (1995-2000) and internal medicine (2001-2002), received her MD and her extraordinary professorship fom the University of Marburg and did research work in the field of health services research and quality improvement. She is author or coauthor of 7 books and over 150 publications.

Vice-Chairs of the Scientific Committee

Keng Ho PweeKeng Ho Pwee (Singapore)

Dr Keng Ho Pwee is a public health physician. He obtained his MBBS in 1991 and his MMed (Public Health) in 1999 from the National University of Singapore and has been working in public health and health administration in the Ministry of Health, Singapore, since 1995. Since 2002, he has been working in the fields of HTA and clinical practice guidelines development in the Ministry of Health. He is a co-opted trustee of the G-I-N Board (2009-2011). He is a member of the editorial board of the International Journal of Technology Assessment in Health Care (IJTAHC) and an associate editor of the Singapore Medical Journal (SMJ).

Amir QaseemAmir Qaseem (USA)

Dr Amir Qaseem is Senior Medical Associate in the Medical Education and Publishing Division at the American College of Physicians (ACP). He is responsible for the American College of Physicians' evidence-based medicine and clinical practice guidelines program, one of the oldest programs in the United States, and writing of the clinical guidelines. He is also responsible for the American College of Physicians' quality improvement programs, implementation of clinical practice guidelines, and is Director of ACPNet, the College's quality improvement network. He is a a member of the G-I-N Board of Trustees since August 2010.

Members of the Scientific Committee

Lubna Al-Ansari.jpgLubna Al-Ansary (Saudi Arabia)

Lubna A Al-Ansary is an Associate Professor at the College of Medicine, Consultant Family Physician at the Primary Care Centre based at King Khalid University Hospital and head of the Clinical Practice Guidelines Committee in both teaching hospitals at King Saud University, the oldest and largest university in Saudi Arabia. She holds Shaikh Bahamdan Research Chair for Evidence-Based Health Care and Knowledge Translation that was established in June 2008 and was heavily involved in evidence generation and capacity building in systematic reviews. It is now delving into the areas of evidence/knowledge implementation and impact evaluation that have largely to do with evidence-based clinical practice guidelines. The Chair managed to get an organizational membership of the G-I-N and secure a nation-wide access by all health care professionals to its contents. Lubna got the Dean's Active Researcher Award in 2010.

Phil Alderson.jpgPhil Alderson (UK)

Phil Alderson is a public health doctor working in the Centre for Clinical Practice at NICE on the methods of guideline development and quality assurance systems for guidelines. He worked at the UK Cochrane Centre from 1996 to 2004, where he was involved in running training programmes for systematic reviewers and co-editing the Cochrane Reviewers Handbook. His interests include methods of research synthesis and effectiveness of interventions for head injury.


Gerd Antes.jpgGerd Antes (Germany)

Gerd Antes (*1949, Neumünster) is a Medical Statistician who holds a position in the department of Medical Biometry in the Institute of Medical Biometry and Medical Informatics at the University of Freiburg i.Br. (Germany). He graduated in mathematics from the University of Bremen in 1976. After a year at the Institute of Biometry at the University of Edinburgh in Scotland he joined the Department of Biometry of Schering AG in Berlin. He worked in various fields of statistical consulting, including among others the design and analysis of clinical trials, risk assessment, quality control and experiments in agriculture. After three years he joined the Institute of Statistics at the University of Bremen. Beside research and teaching he cooperated with the ‘Bremer Institute für Präventivforschung und Sozialmedizin'. In his dissertation he treated the effects of correlated covariables in the analysis of survival times. In 1987 he joined the Department of Medical Statistics in Freiburg i.Br. In 1992 he set up the Unit of Biometry in the ‘Klinik für Tumorbiologie’ in Freiburg’ where he worked mainly in the field of clinical trials in cancer. From there he returned to University where he has been a member of the Department of Medical Biometry & Informatics since the beginning in 1995. Besides interests in methodological work, statistical computing and medical informatics he set up the German Cochrane Centre and stimulated and supported the progress of Evidence-Based Medicine and the Cochrane Collaboration in Germany. Currently Gerd Antes holds a position in the University Hospital in Freiburg. He is director of the German Cochrane Centre and a board member (2001-2003 also chair) of the German Network for Evidence-based Medicine. Since 1998 he is a member of the Cochrane Collaboration’s Steering Group; since 07/2003 Chair of the Advisory Board of the metaRegister of Current Controlled Trials; since 2005 speaker of the initiative for the establishment of a national register for clinical trials; since 2009 member of the advisory board of the German Institute of Medical Documentation and Information.

Brigitte EttlBrigitte Ettl (Austria)

Dr. Brigitte Ettl is currently the medical director of the Hietzing Hospital with the Neurological Center Rosenhügel, which is a part of the Vienna Hospital Association. She is also a consultant for the Austrian Medical Association in the fields of quality assurance, guidelines and patient safety. Dr. Ettl is the chairwoman of ANetPAS which is the Austrian Network for Patient Safety. She holds a degree as academic hospital manager from the Vienna University of Economics and Business and is a certified risk manager. Her vision is to realise the implementation of clinical guidelines in clinical work so we can have more effectivity and quality for the treatment of our patients.

Paul GlasziouPaul Glasziou (Australia)

Paul Glasziou FRACGP, PhD is Professor of Evidence-Based Medicine at Bond University and a part-time General Practitioner. He was the Director of the Centre for Evidence-Based Medicine in Oxford from 2003-2010. His key interests include identifying and removing the barriers to using high quality research in everyday clinical practice. He is the author of six books related to evidence based practice: Systematic Reviews in Health Care, Decision Making in Health Care and Medicine: integrating evidence and values, An Evidence-Based Medicine Workbook, Clinical Thinking: Evidence, Communication and Decision-making, Evidence-Based Medicine: How to Practice and Teach EBM, and Evidence-Based Medical Monitoring: Principles and Practice. He has authored over 160 peer-reviewed journal articles and his h-index is currently 43. He is the recipient of an NHRMC Australia Fellowship which he commenced at Bond University in July, 2010. He is the author of over 150 peer-reviewed publications in medical decision making, clinical trials, systematic reviews and evidence-based medicine. He is editor of the BMJs journal of Evidence-Based Medicine. He is a member of the management committee of the 3 largest clinical trials ever conducted in Australia: the LIPID, FIELD, and ADVANCE studies. He has published 6 books on evidence-based health care and decision making: Systematic Reviews in Health Care; Decision Making in Health Care and Medicine: integrating evidence and values; An Evidence-Based Medicine Workbook; Clinical Thinking: Evidence, Communication and Decision-making; Evidence-Based Medicine: How to Practice and Teach EBM; and Evidence-Based Medical Monitoring: Principles and Practice.

Javier Gracia_June 2011.jpgJavier Gracia (Spain)

Javier Gracia is a physician, specialized in Preventive Medicine and Public Health in Madrid, Spain. He also has three Master degrees: Public Health, Health Services Management and Quality Management. Currently he is working at UETS (Health Technology Assessment Unit in Madrid, Spain). In his current position, he is coordinating projects related to Health Service Research and Evidence-Based Clinical Practice Guidelines (CPG), including public funded projects about shared decision-making (patient decision aids) and CPG-Updating and implementation strategies. He is a member of the methodological working group of “GuiaSalud” (, the Spanish project for evidence based clinical practice guidelines, within the Quality program for the Spanish NHS. In this National Program of CPG in Spain (GuiaSalud), he is also an Advisor in the consultative committee and currently he is the Director of its scientific committee. He is interested on patient involvement, with some publications in this topic, and he is member of the steering committee of three different groups linked to this subject: Guideline International Network Patient and Public Involvement working group (GIN PUBLIC), interest sub-group for patient and citizen involvement, within HTAi (Health Technology Assessment international) and Spanish Patient Involvement working group, within GuiaSalud.

Metin Gulmezoglu.jpgMetin Gülmezoglu (Turkey and Switzerland)

Metin Gülmezoglu qualified as an obstetrician and gynaecologist in Turkey in 1990. He worked as a clinician and researcher in South Africa between 1990-1995 and completed his PhD at Witwatersrand University. Between 1995 and 1998 he worked first at the National Perinatal Epidemiology and then at the UK Cochrane Centre focusing on systematic reviews and the development of the WHO Reproductive Health Library (RHL) project. In 1998 he joined the Department of Reproductive Health and Research, WHO in Geneva as a medical officer. He is the coordinating editor of the RHL, a specialist database in sexual and reproductive health and coordinates research synthesis activities and conducts multicentre research projects on maternal and perinatal health. He has coordinated several large multicentre, multicountry randomized controlled trials and surveys. He is the coordinator of WHO guidelines on postpartum haemorrhage prevention (2007), treatment (2009), labour induction (2010), hypertensive disorders of pregnancy (in press) and optimizing the delivery of key interventions to improve maternal and newborn health through task shifting (in progress).

Basia Kutryba.jpgBasia Kutryba (Poland)

Graduate of the Faculty of Philology, Institute of English Studies at the Jagiellonian University in Cracow, Poland in 1987. Basia Kutryba is a co-founder of the first quality institute in CEE and a Senior Adviser - the National Centre for Quality Assessment in Health Care (NCQA) in Krakow, Poland. She has played the major role in the development of the Polish national, JCAHO based accreditation system and in quality improvement initiatives in other ECC countries as well as in the Middle East. Chair of the EU Working Group on Patient Safety and Quality of Care; Director of the WHO Collaborating Centre for Developing Quality and Safety in Health Systems in Krakow.

Founding member of the Polish Society for Quality Promotion in Health Care (TPJ -1993) and its Honorary Secretary of the Board since 1998. President of the European Society for Quality in Healthcare – ESQH (2007 – 2010); recently the Immediate Past President of ESQH.

Monika LelgemannMonika Lelgemann (Germany)

Monika Lelgemann is working at the Medical Advisory Service of the German Health Insurance Funds as medical doctor and clinical epidemiologist. She is head of the department for evidence-based medicine mainly occupied with health technology assessment on commission of the statutory health insurance funds. Since March 2011 Monika Lelgemann is elected chair of the German Network for Evidence Based Medicine (DNEbM), a network of 900 scientists, doctors, nurses and members from other professions with the aim to implement and further enhance methods of evidence-based medicine. Dr. Lelgemann is also member of the AWMF’s Standing Commission for Clinical Practice Guidelines and head of the scientific advisory committee of the German Agency for Health Technology Assessment of DIMDI (DAHTA@DIMDI).

Dr. Lelgemann received her medical education in Marburg und Göttingen, her training in clinical epidemiology at the Erasmus University in Rotterdam, Netherlands. She is trained anesthesist with expert knowledge in clinical pharmacology. Dr. Lelgemann has been involved in guideline development and health technology assessment at different institutions in Germany over the past 15 years. During her time at the German Agency for Quality in Medicine she was responsible for the National Disease Management Guidelines Programme and the German Guideline Clearinghouse.

Joseph Mathew.jpgJoseph L. Mathew (India)

Dr. Joseph L. Mathew is a Pediatric Pulmonologist at the Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Dr. Mathew has developed expertise in three areas of health-care viz pediatric respiratory disease, immunization/ vaccines of public health importance, and evidence-informed health-care. He has published 105 papers in scientific journals and several chapters in text books. Dr. Mathew has been a pioneer of the Evidence Based Medicine (EBM) movement in India; he was a founding member of the South Asian Cochrane Network, which achieved the status of a full-fledged Cochrane Centre in April 2008. He continues to be a Member of the Steering Group of the South Asian Cochrane Centre. He is an author/co-author of 5 Cochrane reviews, and is active as a peer reviewer, critic and Teaching Faculty at several national and international Cochrane Collaboration and other EBM workshops/training programmes. Dr. Mathew is the lead author and section Editor of EURECA (Evidence that is Understandable, Relevant, Extendible, Current and Appraised) in Indian Pediatrics. He has published 18 systematic reviews on topics of child health relevant to developing countries. He has been a Chair/Member of national committees for the preparation of evidence-based guidelines on Pediatric immunization, management of childhood pneumonia and Pediatric Tuberculosis. Dr. Mathew’s main focus has been the applicability of external evidence to developing country settings. He has attempted to bridge the gap between research evidence and clinical practice through his involvement with Health Technology Assessment (HTA). He is the Founder Chair of the HTAi Interest Sub-Group on Developing Countries; in this capacity he leads a group of committed professionals to facilitate scientific practice of health-care decision-making in developing countries. He is the Leader and Programme Manager of the SIGNET Programme for Capacity and Capability Building of health-care professionals in the science of evidence-informed decision-making in health-care. Through this programme, he has conducted 13 Training Workshops in India and abroad. Dr. Mathew is a sought after speaker and has presented at international Conferences including 3 HTAi Annual Meeting; 3 Cochrane Colloquium, and the 2010 SMDM Annual Meeting.

Douglas K OwensDouglas K. Owens (USA)

Douglas K. Owens, MD, MS is a general internist and a Senior Investigator at the Center for Health Care Evaluation at the VA Health Care System, Palo Alto, and a Professor of Medicine and of Health Research and Policy at Stanford University, where he directs the Program on Clinical Decision Making and Guideline Development at Stanford Health Policy. Dr. Owens also directed the Stanford University-UCSF Evidence-Based Practice Center. Dr. Owens chaired the guideline development committee for the American College of Physicians for four years and was a member of the committee for nine years. During this time, he participated in the development of over 20 national guidelines. His research focuses on the decision sciences, evidence synthesis, technology assessment, cost-effectiveness analysis and guideline development. He is a past President of the Society for Medical Decision Making. Dr. Owens was elected to the American Society for Clinical Investigation (ASCI), and the Association of American Physicians (AAP). In 2007, Dr. Owens received the VA Under Secretary’s Award for Outstanding Achievement in Health Services Research. In 2010, he received the John Eisenberg Award from the Society for Medical Decision Making for sustained leadership in translating medical decision making research into practice.

Holger Schünemann

Holger Schünemann (Canada)

As internist and clinical epidemiologist, Holger J. Schünemann holds the position of chair of the department of Clinical Epidemiology and Biostatistics at McMaster University, Hamilton, Canada, widely regarded the birthplace of Evidence Based Medicine and Problem Based Learning. McMaster University consistently ranks amongst the top 100 Universities in the world. Dr. Schünemann graduated from the Medical School of Hannover, Germany, and trained in epidemiology (Ph.D. in 2000), preventive medicine/public health and internal medicine at the Medical School of Hannover, Germany, and at the State University of New York (SUNY) at Buffalo, USA. He authored over 300 peer reviewed publications, books and book chapters, many of them focusing on guideline methodology and systematic reviews. He co-convenes the Applicability and Recommendations Method Group of the Cochrane Collaboration and is co-chair of the GRADE working group. In 2011 he became a member of the Advisory Committee on Health Research (ACHR) at WHO and has chaired various guideline expert panels at the World Health Organization, including on the management of Avian Influenza and recent new molecular techniques of testing for multi drug resistant tuberculosis. He also is a member of the American College of Physicians Clinical Guideline Committee, the American Thoracic Society Documents Development and Implementation Committee and the American College of Chest Physicians Antithrombotic Therapy Guidelines Executive Committee.

Nandi SiegfriedNandi Siegfried (South Africa)

Nandi Siegfried is a public health medicine specialist and is currently Co-director of the South African Cochrane Centre based at the Medical Research Council. She has a MBChB degree a (1993) and a Masters in Public Health (Honours-2000), and holds a Fellowship in Public Health Medicine (2004). She was a Nuffield Medical Fellow at the University of Oxford from 2004 to 2007, where she was based at the Clinical Trials Service Unit obtaining a DPhil degree in Clinical Epidemiology. She is an active member of the international organization, the Cochrane Collaboration, and in 2000 established the Cochrane HIV/AIDS Mentoring Programme to train novice African researchers in meta-analytic methods. Her current research focuses on the methodological quality and conduct of randomized controlled trials of HIV/AIDS interventions and explores the feasibility and sustainability of a national trials support centre to enhance the quality, conduct and translation of trial research in the South African public health sector. In 2009 she contributed to the development of World Health Organization guidelines for anti-retroviral treatment for people living with HIV/AIDS and is currently involved in a project appraising guidelines for the Southern African Regional Programme on Access to Medicines.

Stig SloerdahlStig Slørdahl (Norway)

Stig A. Slørdahl is Dean at The Faculty of Medicine at the Norwegian University of Science and Technology in Trondheim, Norway. He is a professor in Cardiovascular Physiology and a Consultant Physician in Cardiology at St. Olavs Hospital in Trondheim. Professor Slørdahl is Chair of The Joint Committee of the Nordic Medical Research Councils and member of the Core Group of The European Medical Research Councils. He was Co-Chair for the Forward Look from the European Science Foundation: Implementation of Medical Research in Clinical Practice. He is a former member of the Committee for Priority and Quality for Health Services in Norway.

Joachim Szecsenyi_smaller.jpg

Joachim Szecsenyi (Germany)

Joachim Szecsenyi is Professor and Medical Director at the Department of General Practice and Health Services Research, University of Heidelberg Hospital. He is also co-founder and director of the Institute for Applied Quality Improvement and Research in Health Care (AQUA) in Goettingen. This organisation -among other activities- is a contractor for the Federal Joint Committee (G-BA) and is responsible for the nationwide program for hospital benchmarking and for cross-sectoral quality improvement. Dr. Szecsenyi has 25 years of experience with quality of care research and health services research in primary medical care, hospitals and care networks. His work comprises 10 books and more than 250 scientific publications. From 2001-2006 he was president of the European Association for Quality in Primary Care (Equip). From 1995-2010 he was involved in the guideline program of the German College of Family Physicians (DEGAM). He was a practising physician in a rural family practice for almost 10 years.


Trudy van der Weijden (Netherlands)

Trudy van der Weijden received her medical degree in 1989 and made a choice for fulltime research early in her career. She certified as epidemiologist, and is now appointed as professor in Implementation of Clinical Practice Guidelines at the department of General Practice of Maastricht University. She is leading one of the research programs of the School for Public Health and Primary Care (Caphri), called 'Implementation of evidence'. Her studies are about knowledge transfer; defining and describing quality of care, and improving quality of care through implementation of guidelines and innovations. Her research has a specific focus on the patient perspective and patient participation in medical decision-making where the tension is felt between rationalizing work (the application of guidelines) and patient-centered work (the practice of the consultation). She is visiting senior fellow at Nijmegen IQ Scientific Institute for Quality of Health Care, working with Richard Grol, the Netherlands, and at the Cardiff Department of Primary Care and Public Health, working with Glyn Elwyn, UK.

Jurgen Windeler.jpgJürgen Windeler (Germany)

On September 1, 2010 Jürgen Windeler, MD, was appointed Director of the German Institute for Quality and Efficiency in Health Care (IQWiG). IQWiG evaluates medical services in an effort to promote evidence-based medical practice. It is mainly commissioned by and provides scientific advice to the German Federal Joint Committee and the German Federal Ministry of Health. Prof. Windeler received his medical and academic education in Göttingen, Lübeck, Düsseldorf and Wuppertal and was awarded a doctorate in medicine in 2001. He was Research Associate at the Department of Medical Informatics and Biomathematics at the Ruhr University of Bochum from 1988 to 1993. From 1993 to 1999 he was Deputy Head of the Department of Medical Biometry at the Ruprechts-Karls-University Heidelberg. Since 2001 he has held an extraordinary professorship in Medical Biometry and Clinical Epidemiology at the Ruhr-University Bochum. Prof. Windeler headed the Department of Evidence-based Medicine at the Medical Advisory Service of the German Health Insurance Fund (1999 to 2004), where he also held the post of Deputy Chief Executive and Chief Physician from 2004-2010. He has published in peer-reviewed journals and was a member of several advisory committees, among them a group of experts on “off label use” at the Federal Institute for Drugs and Medical Devices (2003-2005). He was head of the German Network for Evidence Based Medicine DNEbM from 2005 to 2007. In September of 2010 he was appointed to the Health Research Council by the Federal Ministry of Education and Research.

Page last updated: Oct 27, 2011
Back to top